GSDME and neoplasm: In mouse models of colon and breast cancer, tubulysin, a microtubule depolymerizing agent, can trigger tumor cell death by targeting the GSDME-mediated pyroptotic pathway and modulating tumor sensitivity to ADC treatment [162].